$30.98 +0.78 (2.58%)

Omnicell Inc (OMCL)

Omnicell Inc (OMCL) is a healthcare technology company that specializes in medication management solutions, including automation and robotics for hospitals, long-term care, and retail pharmacy settings. Its products and services aim to improve medication safety, operational efficiency, and clinical outcomes through automation systems, inventory management, and analytics. Founded in 1992 and headquartered in Mountain View, California, Omnicell is recognized for its innovation in healthcare automation.

🚫 Omnicell Inc does not pay dividends

Company News

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
GlobeNewswire Inc. • Daniel Kontoh-Boateng • August 26, 2025

Evoke Pharma partnered with EVERSANA and Omnicell to expand access to GIMOTI nasal spray for gastroparesis treatment, targeting large gastroenterology practices and specialty pharmacies through strategic pharmacy network agreements.

Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Benzinga • Lekha Gupta • November 3, 2024

Several mid-cap stocks, including Globalstar, V.F. Corp, and Madrigal Pharmaceuticals, were among the top gainers last week. The companies reported positive financial results and business updates, leading to the stock price increases.

Here's Why Omnicell (OMCL) Should be in Your Portfolio Now
Zacks Investment Research • Zacks Equity Research • June 10, 2024

A robust Advanced Services portfolio and strategic restructuring initiatives bode well for Omnicell (OMCL).

Here's one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
MarketWatch • MarketWatch • March 22, 2023

Everyone is watching the banks, but what about healthcare. It's breaking out, says this strategist.

What Happened This Week: Buyback Tax Trend And All Atwitter @ Twitter
Investing.com • Brenda O'Farrell/Investing.com • November 4, 2022

Related Companies